Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

10 treatments under study, led by Droperidol And Ondansetron

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 4 (1)

Trial Status

Completed4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Droperidol And Ondansetron1
  • Droperidol And Saline1
  • Ondansetron1
  • Droperidol1
  • Propofol1

Active Sponsors

  • University of British Columbia3
  • The Third People's Hospital of Hangzhou1
  • British Columbia Childrens Hospital Foundation1

Top Investigators

Related Conditions

  • Dermatomyositis1
  • Healthy1
  • Inflammation1

Activity Timeline